Lymphoproliferative response in primary human cytomegalovirus (HCMV) infection is delayed in HCMV transmitter mothers

Journal of Infectious Diseases

Volumn 193, Issue 2, 2006, Pages 269-276

  Revello, Maria Grazia ^a   Lilleri, Daniele ^a   Zavattoni, Maurizio ^a   Furione, Milena ^a   Genini, Emilia ^a   Comolli, Giuditta ^a   Gerna, Giuseppe ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CYTOKINE FLOW CYTOMETRY; CYTOMEGALOVIRUS INFECTION; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; VIRUS CARRIER; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE TRANSMISSION, VERTICAL; DNA, VIRAL; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE DEPLETION; LYMPHOCYTE SUBSETS; MIDDLE AGED; MOTHERS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 30944438250     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/498872     Document Type: Article

References (35)

1. Pass RF. Cytomegalovirus. In: Fields BN, Howley PM, eds. Fields virology. 4th ed. Vol 2. Philadelphia: Lippincott Williams & Wilkins, 2001:2675-706.
2. Stagno S, Pass RF, Dworsky ME, et al. Congenital cytomegalovirus infection: the relative importance of primary and recurent maternal infection. N Engl J Med 1982; 306:945-9.
3. Rinaldo CR, Carney WP, Richter BS, Black PH, Hirsch MS. Mechanisms of immunosuppression in cytomegaloviral mononucleosis. J Infect Dis 1980; 141:488-95.
4. Zanghellini F, Boppana SB, Emery VC, Griffiths PD, Pass RF. Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J Infect Dis 1999; 180:702-7.
5. Stern H, Hannington G, Booth J, Moncrieff D. An early marker of fetal infection after primary cytomegalovirus infection in pregnancy. Br Med J (Clin Res Ed) 1986; 292:718-20.
6. Fernando S, Pearce JM, Booth JC. Lymphocyte responses and virus excretion as risk factors for intrauterine infection with cytomegalovirus. J Med Virol 1993; 41:108-13.
7. Meyers JJD, Flournoy N, Thomas E. Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant. J Infect Dis 1980; 142:816-24.
8. Reusser P, Riddell S, Meyers J, Greenberg P. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 1991; 78:1373-80.
9. + T cells during primary cytomegalovirus infection. J Clin Invest 2000; 105:541-8.
10. + T cells in protection against CMV disease. Blood 2003; 101:2686-92.
11. + T cell frequency and lymphoproliferative response in human immunodeficiency virus-positive patients. Clin Diagn Lab Immunol 2001; 8:1225-30.
12. Gerna G, Piccinini G, Genini E, et al. Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART. J Acquir Immune Defic Syndr 2001; 28:320-31.
13. Revello MG, Zavattoni M, Sarasini A, Percivalle E, Simoncini L, Gerna G. Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognostic implications for pregnancy. J Infect Dis 1998; 177:1170-5.
14. Revello MG, Zavattoni M, Furione M, Lilleri D, Gorini G, Gerna G. Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infections. J Infect Dis 2002; 186:553-7.
15. Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus and newborn infant. Clin Microbiol Rev 2002; 15:680-715.
16. Gerna G, Revello MG, Palla M, Percivalle E, Torsellini M. Microneutralization as a reference method for selection of the cut-off of an enzyme linked immunosorbent assay. Microbiologica 1992; 15:177-82.
17. Revello MG, Percivalle E, Zannino M, Rossi V, Gerna G. Development and evaluation of a capture ELISA for IgM antibody to the human cytomegalovirus major DNA binding protein. J Virol Methods 1991; 35:315-29.
18. Gerna G, Revello MG, Percivalle E, Morini F. Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. J Clin Microbiol 1992; 30:1232-7.
19. Gerna G, Revello MG, Percivalle E, Zavattoni M, Parea M, Battaglia M. Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins. J Clin Microbiol 1990; 28: 2681-8.
20. Revello MG, Sarasini A, Zavattoni M, Baldanti F, Gerna G. Improved prenatal diagnosis of congenital human cytomegalovirus infection by a modified nested polymerase chain reaction. J Med Virol 1998; 56:99-103.
21. Revello MG, Zavattoni M, Baldanti F, Sarasini A, Paolucci S, Gerna G. Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns. J Clin Virol 1999; 14:57-66.
22. Sabahi F, Rola-Plesczcynski M, O'Connell S, Frenkel LD. Qualitative and quantitative analysis of T lymphocytes during normal human pregnancy. Am J Reprod Immunol 1995; 33:381-92.
23. Gehrz RC, Christianson WR, Linner KM, Conroy MM, McCue SA, Balfour HH. Cytomegalovirus-specific humoral and cellular immune responses in human pregnancy. J Infect Dis 1981; 143:391-5.
24. Gehrz RC, Christianson WR, Linner KM, Conroy MM, McCue SA, Balfour HH. A longitudinal analysis of lymphocyte proliferative responses to mitogens and antigens during human pregnancy. Am J Obstet Gynecol 1981; 140:665-70.
25. Levin MJ, Rinaldo CR, Lwary PL, Zaia JA, Hirsch MS. Immune response to herpesvirus antigens in adults with acute cytomegalovirus mononucleosis. J Infect Dis 1979; 140:851-7.
26. Tanaka R, Tanaka A, Oizumi Y, Ishida N, Numazaki Y. Virus excretion and cell-mediated immunity during cytomegalovirus infection among healthy infants and children. J Med Virol 1986; 18:21-7.
27. Pass RF, Dworsky ME, Whitley RJ, August AM, Stagno S, Alford CA. Specific lymphocyte blastogenic responses in children with cytomegalovirus and herpes simplex virus infections acquired in early infancy. Infect Immun 1981;34:166-70.
28. Pass RF, Stagno S, Britt WJ, Alford CA. Specific cell-mediated immunity and the natural history of congenital infection with cytomegalovirus. J Infect Dis 1983; 148:953-61.
29. Starr SE, Tolpin MD, Friedman HM, Paucker K, Plotkin SA. Impaired cellular immunity to cytomegalovirus in congenitally infected children and their mothers. J Infect Dis 1979; 140:500-5.
30. Gehrz RC, Marker SC, Knor SO, Kalis JM, Balfour HH. Specific cell-mediated immune defect in active cytomegalovirus infection of young children and their mothers. Lancet 1977; 2:844-7.
31. Reynolds DW, Dean PH, Pass RF, Alford CA. Specific cell-mediated immunity in children with cytomegalovirus infection and their mothers. J Infect Dis 1979; 140:493-9.
32. Auphan-Anezin N, Verdeil G, Schmitt-Verhulst AM. Distinct thresholds for CD8 T cell activation lead to functional heterogeneity: CD8 T cell priming can occur independently of cell division. J Immunol 2003; 170:2442-8.
33. Mannering SI, Morris JS, Jensen KP, et al. A sensitive method for detecting proliferation of rare autoantigen-specific human T cells. J Immunol Methods 2003; 283:173-83.
34. Rinaldo CR Jr, DeBiasio RL. Alteration of immunoregulatory mechanisms during cytomegalovirus mononucleosis: effect of in vitro culture on lymphocyte blastogenesis to viral antigens. Clin Immunol Immunopathol 1983; 28:46-55.
35. + T cells by a novel method using monocyte-derived HCMV-infected immature dendritic cells. Eur J Immunol 2005; 35:1795-804.